AFT Pharmaceuticals Limited (AFP.AX)
AUD 2.55
(-1.54%)
AUD 2.55
(-1.54%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 28.86 Million | 11.62 Million | 14.15 Million | 750 Thousand | 14.87 Million | 1.06 Million |
| Net Income | 15.6 Million | 10.65 Million | 19.84 Million | 7.78 Million | 12.69 Million | -2.42 Million |
| Depreciation & Amortization | 2.01 Million | 848 Thousand | 913 Thousand | 975 Thousand | 956 Thousand | 243 Thousand |
| Deferred income taxes | - | - | 4.79 Million | 15.43 Million | 4.75 Million | 2.54 Million |
| Stock-based compensation | 139 Thousand | - | 13 Thousand | 44 Thousand | 114 Thousand | 252 Thousand |
| Change in working capital | -4.16 Million | -19.61 Million | -4.8 Million | -15.47 Million | -4.87 Million | -2.79 Million |
| Other non-cash items | 15.4 Million | 19.74 Million | -6.6 Million | -8 Million | 1.23 Million | 3.25 Million |
| Investing Cash Flow | -9.52 Million | -9.17 Million | -5.58 Million | -6.23 Million | -6.56 Million | -4.88 Million |
| Investments in PPE | -9.52 Million | -197 Thousand | -329 Thousand | -93 Thousand | -92 Thousand | -140 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | -1.41 Million |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -9.41 Million | -8.98 Million | -5.25 Million | -6.13 Million | -6.47 Million | -3.32 Million |
| Financing Cash Flow | -10.63 Million | -6.97 Million | -2.27 Million | 2.52 Million | -9.11 Million | 3.72 Million |
| Debt repayment | -5 Million | -4.59 Million | -5.37 Million | -7.13 Million | -60.85 Million | -7.41 Million |
| Dividends payments | -1.15 Million | - | - | -188 Thousand | -566 Thousand | -134 Thousand |
| Common Stock Repurchased | - | - | - | -723 Thousand | 60.85 Million | - |
| Common Stock Issuance | - | 475 Thousand | 295 Thousand | 12.39 Million | 3000.00 | - |
| Other Financing Activities | -793 Thousand | -2.86 Million | 2.8 Million | -1.83 Million | -8.55 Million | 3.85 Million |
| Accounts receivables | 2.49 Million | -10.71 Million | -4.96 Million | -4.55 Million | -7.29 Million | -2.05 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -6.66 Million | -8.89 Million | 154 Thousand | -10.92 Million | 2.42 Million | -746 Thousand |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 3.29 Million | 7.94 Million | 3.2 Million | 6.11 Million | 6.91 Million | 6.77 Million |
| Cash at end of period | 12.04 Million | 3.29 Million | 7.94 Million | 3.2 Million | 6.11 Million | 6.91 Million |
| Capital Expenditure | -9.52 Million | -197 Thousand | -329 Thousand | -93 Thousand | -92 Thousand | -140 Thousand |
| Effect of forex changes on cash | 48 Thousand | -123 Thousand | 101 Thousand | 49 Thousand | 5000.00 | 240 Thousand |
| Net cash flow / Change in cash | 8.74 Million | -4.64 Million | 4.73 Million | -2.91 Million | -797 Thousand | 146 Thousand |
| Free Cash Flow | 19.33 Million | 11.43 Million | 13.82 Million | 657 Thousand | 14.78 Million | 927 Thousand |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 15.6 Million | 13.79 Million | 1.81 Million | 9.1 Million | 10.65 Million | 1.54 Million |
| Depreciation & Amortization | 2.01 Million | 351 Thousand | 848 Thousand | -171 Thousand | 848 Thousand | 1.01 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 139 Thousand | 139 Thousand | - | - | - | - |
| Change in working capital | -4.16 Million | -5.22 Million | 1.05 Million | -20.85 Million | -19.61 Million | 1.24 Million |
| Other non-cash items | 15.4 Million | 12.33 Million | 3.74 Million | 17.56 Million | 19.74 Million | 2.17 Million |
| Investing Cash Flow | -9.52 Million | -4.68 Million | -4.84 Million | -4.32 Million | -9.17 Million | -4.85 Million |
| Investments in PPE | -9.52 Million | -40 Thousand | -76 Thousand | -82 Thousand | -197 Thousand | -115 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -9.41 Million | -4.64 Million | -4.76 Million | -4.24 Million | -8.98 Million | -4.73 Million |
| Financing Cash Flow | -10.63 Million | -7.36 Million | -3.26 Million | -3.93 Million | -6.97 Million | -3.04 Million |
| Debt repayment | -5 Million | - | -331 Thousand | - | -4.59 Million | -2.3 Million |
| Dividends payments | -1.15 Million | - | -1.15 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | 475 Thousand | - |
| Other Financing Activities | -793 Thousand | -7.36 Million | -1.78 Million | -3.93 Million | -2.86 Million | -746 Thousand |
| Accounts receivables | 2.49 Million | -10.81 Million | 13.3 Million | -18.16 Million | -10.71 Million | 7.45 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -6.66 Million | 5.59 Million | -12.25 Million | -2.69 Million | -8.89 Million | -6.2 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 3.29 Million | 2.58 Million | 3.29 Million | 5.79 Million | 7.94 Million | 7.94 Million |
| Cash at end of period | 12.04 Million | 12.04 Million | 2.58 Million | 3.29 Million | 3.29 Million | 5.79 Million |
| Capital Expenditure | -9.52 Million | -40 Thousand | -76 Thousand | -82 Thousand | -197 Thousand | -115 Thousand |
| Effect of forex changes on cash | 48 Thousand | 106 Thousand | -58 Thousand | 103 Thousand | -123 Thousand | -226 Thousand |
| Net cash flow / Change in cash | 8.74 Million | 9.45 Million | -704 Thousand | -2.5 Million | -4.64 Million | -2.14 Million |
| Free Cash Flow | 19.33 Million | 21.35 Million | 7.39 Million | 5.56 Million | 11.43 Million | 5.86 Million |
TSCDY
SMAWF
FSS
CRANESSOFT
BRFS
CX